Jane Smith*
Brain tumors are a heterogeneous group of neoplasms with significant implications for neurological health and overall survival. The diversity in tumor biology, from benign to highly malignant forms, complicates diagnosis and treatment. This review explores the epidemiology, classification, clinical presentation, diagnostic innovations, and therapeutic advancements in brain tumor management. Special attention is given to emerging technologies like molecular profiling and immunotherapy. Despite progress, challenges such as tumor heterogeneity, treatment resistance, and late diagnosis persist, necessitating continued research to improve patient outcomes and quality of life.